Request Demo
Last update 29 Aug 2025
Jiangsu Zhongxin Pharmaceutical Co., Ltd.
Last update 29 Aug 2025
Overview
Tags
Endocrinology and Metabolic Disease
Other Diseases
Eye Diseases
Fc fusion protein
Growth factors
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20252333
长效GLP-1/GIP双重受体激动剂（ZX2010）注射液在中国2型糖尿病受试者中的有效性和安全性的随机、双盲、安慰剂对照Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase II clinical trial of the efficacy and safety of a long-acting GLP-1/GIP dual receptor agonist (ZX2010) injection in Chinese subjects with type 2 diabetes
CTR20251509
重组人神经生长因子（ZX1305）滴眼液治疗神经营养性角膜炎的多中心、随机、双盲、安慰剂对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial of recombinant human nerve growth factor (ZX1305) eye drops in the treatment of neurotrophic keratitis
CTR20250527
在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药代动力学特征的多中心、随机、双盲、安慰剂平行对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy, safety and pharmacokinetic characteristics of ZX2021 injection in non-diabetic overweight or obese subjects
100 Clinical Results associated with Jiangsu Zhongxin Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Jiangsu Zhongxin Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Zhongxin Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Sep 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
4
3
Phase 2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free